Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Marion L. Williams; Pankaj Bhargava; Ilham Cherrouk; John L. Marshall; David A. Flockhart; Irving W. Wainer (Profiled Author: David A. Flockhart)
British Journal of Clinical Pharmacology. 2000;49(5):485-488.Abstract
Aims. To examine the relationship between cytochrome P450 2C19 (CYP2C19) genotype and expressed metabolic activity in 16 patients with advanced metastatic cancer. Methods. Individual CYP2C19 genotypes were determined by PCR-based amplification, followed by restriction fragment length analysis, and compared with observed CYP2C19 metabolic activity, as determined using the log hydroxylation index of omeprazole. Results. All 16 patients had an extensive metabolizer genotype. However, based on the antimode in a distribution of log omeprazole hydroxylation indices from healthy volunteers, four of the patients had a poor metabolizer phenotype and there was a general shift of the remaining 12 patients towards a slower metabolic phenotype. This suggests a reduction in metabolic activity for all patients relative to healthy volunteers. A careful analysis of patient medical records failed to reveal any drug interactions or other source for the observed discordance between genotype and phenotype. Conclusions. There are no previous reports of a 'discordance' between genotype and expressed enzyme activity in cancer patients. Such a decrease in enzyme activity could have an impact on the efficacy and toxicity of chemotherapeutic agents and other drugs, used in standard oncology practice.
PMID: 10792207 PMCID: PMC2014949
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
John D. Balian; Nadia Sukhova; James W. Harris; Jan Hewett; Linda Pickle; Joyce A. Goldstein; Raymond L. Woosley; David A. FlockhartClinical Pharmacology and Therapeutics. 1995;57(6):662-669.
J.C. Gorski; D.R. Jones; S.A. Wrighton; S.D. HallXenobiotica. 1997;27(3):243-256.
Ji-Hong Shon; Young-Ran Yoon; Kyoung-Ah Kim; Young-Chae Lim; Kwang-Jae Lee; Ji-Young Park; In-June Cha; David A. Flockhart; Jae-Gook ShinPharmacogenetics. 2002;12(2):111-119.
Appears in this Document